Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic is a research paper published in Journal of Clinical and Translational Science (2021). On theSindex it has a DataRank of 0.664. It has been cited 11 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0.291
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
NCATS NIH HHS
Grant: U01 TR002488
NCATS NIH HHS
Grant: U24 TR002260
NCATS NIH HHS
Grant: UL1 TR003142
National Institutes of Health
Grant: 5U01TR002488-03
TEAMSS – Transforming Expanded Access to Maximize Support & Study
National Institutes of Health
Grant: 5U24TR002260-04
CTSA Coordinating Center for Leading Innovation and Collaboration (CLIC)
National Institutes of Health
Grant: 3UL1TR001881-01S2
UCLA Clinical Translational Science Institute
National Institutes of Health
Grant: 5UL1TR003142-03
Stanford Center for Clinical & Translational Education and Research (Spectrum)
National Institutes of Health
Grant: 5UL1TR002240-02
Michigan Institute for Clinical and Health Research (MICHR)
FWCI
0.91
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals